Public health leaders warn dwindling COVID data risks less preparation for ‘the next outbreak’

Public health leaders warn dwindling COVID data risks less preparation for ‘the next outbreak’
Public health leaders warn dwindling COVID data risks less preparation for ‘the next outbreak’
TAMI CHAPPELL/AFP via Getty Images

(NEW YORK) — While COVID-19 ebbs — and many of the pandemic-era policies on surveillance data and funding wind down with it — the nation’s public health leaders warned senators on Thursday that a return to “normal” should not mean forgetting the hard lessons learned over the last three years.

When the federal government’s public health emergency expires next week, COVID-19 data collection tools will also end. Those tools have been described as vital to staying vigilant and preparing for emerging health threats.

“Infectious disease threats have been emerging at an increased pace and are increasingly complex,” Centers for Disease Control and Prevention Director Rochelle Walensky told the Senate Health, Education, Labor, and Pensions (HELP) Committee. “These diseases don’t respect national or state borders, and the increased frequency of outbreaks means that we should not be asking if we will face another serious public health threat — but when.”

Though “for many life has turned to normal after three years of COVID-19,” Walensky said it’s the mission of public health to “remain response-ready to protect Americans from any resolving or emerging health threat,” which can only be done by “actively supporting the core capabilities of public health.”

Thursday’s hearing was part of the process to reauthorize the Pandemic and All-Hazards Preparedness Act, which was first signed into law in 2006 and has been regularly reauthorized since then.

“The approaching end of the public health emergency once again reminds us that policy changes and funding are essential to the readiness of future bio-threats. The CDC will continue to closely monitor COVID-19 and provide the information to which we have access,” Walensky said.

She and other panelists emphasized that caveat: The limited access to data that comes along with a return to “normal” threatens to kneecap future surveillance efforts.

“We will adapt to limitations and utilize tried-and-true systems to monitor other respiratory diseases, to keep our eye on COVID-19,” Walensky said, “but there are data we will no longer have available because they will no longer be submitted to us. For example, certain data for a national picture of health disparities both for race and ethnicity and along urban and rural lines.”

“We will make do,” the CDC director said. “However this should worry us all, primarily because of what it says about the visibility we will have into the next outbreak. We will be back to square one — having to build and negotiate surveillance capacity while we fight a pathogen.”

Dawn O’Connell, the U.S. Department of Health and Human Services’ assistant secretary for preparedness and response, said that the U.S. actually was more prepared for COVID-19 than it would’ve been for other types of pandemics because of two prior respiratory outbreaks.

Neglecting to further that work would put the country at a big risk, O’Connell said.

“This is one of my biggest worries, is that we are losing time in preparing for the next pandemic,” she said. “I know it doesn’t feel like it, but the one place we were lucky when it came to the coronavirus is we had already done a lot of the early work on that because of SARS and MERS. We need to get the same head start.”

That’s something some senators looked to explicate in their line of questioning, with Sen. Bernie Sanders, I-Vt., interjecting: “Are you telling us that we have not done the kind of work you would like to see done in preparation for what might be coming?”

“Correct,” O’Connell said.

Another tragedy briefly cast a shadow over Thursday’s hearing, as Walensky opened her remarks by noting that one of the CDC’s employees was killed Wednesday in a mass shooting in Atlanta.

Amy St. Pierre “was a valued member of our team at the Division of Reproductive Health where she worked every day to save the lives of mothers and infants,” Walensky said.

Copyright © 2023, ABC Audio. All rights reserved.

FDA considers whether a birth control pill could be sold over the counter

FDA considers whether a birth control pill could be sold over the counter
FDA considers whether a birth control pill could be sold over the counter
Courtesy of Angela Maske

(WASHINGTON) — Angela Maske was a college freshman in Washington, D.C., when she first had trouble getting a prescription for birth control pills.

Her Catholic-affiliated university wouldn’t prescribe the medication to students as a sexual contraceptive, so Maske spent three months looking for another doctor’s appointment.

More recently, her telehealth provider stopped servicing her area, sending Maske scrambling to find another provider and a new prescription on short notice while juggling a full-time job.

Maske now works with Free the Pill, a coalition of advocates that’s spent years dedicated entirely to increasing public access to contraception — a goal they say is critical to people already struggling to access health care, find time off work or arrange for child care to make a doctor’s appointment.

“It’s just frustrating because (getting a prescription) feels like yet another barrier that people have to go through to access essential care to control their reproductive and sexual autonomy,” said Maske.

The Food and Drug Administration is on the cusp of deciding whether at least one type of hormonal birth control — a progestin-only drug called “Opill” by French drugmaker HRA Pharma — is safe enough to be sold over the counter without a prescription and without age restrictions.

First approved by the FDA in 1973, Opill is type of hormonal birth control pill known as the “minipill,” which poses fewer risks than combination pills that rely on estrogen. Still, buyers would have to screen themselves for any health risk factors, much as they would other over-the-counter medications.

FDA’s panel of scientific advisers are expected to meet next week to discuss the application, and if the agency signs off the drug in coming weeks, the product could be on shelves this summer.

“It is just super exciting that we’ve gotten here at this moment. It’s really historic,” said Kelly Blanchard, president of Ibis Reproductive Health, an advocacy organization that has long called for over-the-counter birth control pills.

Blanchard said she hopes other types of birth control pills will follow suit and that states embrace laws requiring insurance companies to cover the costs. Currently, federal law requires free contraception “as prescribed” by a health care provider, although some states have pushed their own mandates for insurance to cover over-the-counter options as well.

The question over increased access to birth control comes amid a heated national debate on women’s reproductive rights with the overruling of Roe vs. Wade, which guaranteed a constitutional right to abortion. At least 15 states have barred nearly all abortions so far.

This week, New York Democratic Gov. Kathy Hochul signed a law that authorizes pharmacists to dispense hormonal birth control. Patients there can now rely on a single long-standing order from a doctor, rather than having to return for an updated prescription; if the person does not have a health care provider, the pharmacist could dispense the drug anyway with instructions to consult a doctor.

The vast majority of Americans back widespread access to birth control. Two-thirds of adult women under 50 say they are using some form of contraception, with a third of those relying on birth control pills, according to a 2022 KFF (Kaiser Family Foundation) survey.

Most patients also believe they can screen themselves for risk factors when it comes to hormonal birth control. According to KFF, an estimated 77% of women under 50 say they want birth control pills available without a doctor’s prescription if research shows it’s safe and effective.

One concern is that patients will forgo routine examinations if doctors can be cut out of the process. Still, HRA Pharma’s federal application for Opill solicited significant support from the medical community, anti-poverty organizations and reproductive-rights advocates that say increasing access to family planning will benefit millions of people, particularly those in rural areas and people of color who struggle to access any health care.

The American Medical Association, for example, told the FDA that decades of data shows the benefits of “widespread, nonprescription availability far outweigh the limited risk associated with their use.”

In a separate filing, the American College of Obstetricians and Gynecologists said a patient doesn’t need to be examined or tested before taking the drug and that the birth control pill was overwhelmingly safe for most people to take on their own. And while routine exams are critical to a person’s overall health, the group says that shouldn’t be a reason to make birth control harder to access.

Opponents of the move cited medical risk and teen access as a reason to limit access.

“Even if they read the package insert, evidence documents that teenagers take risks disproportionate to their own safety needs. When this is compounded by the lack of parental notification or health provider supervision, the results could be catastrophic,” wrote an objection signed by several Catholic groups, including the US Conference of Catholic Bishops.

Maia Lopez, a 17-year-old high school junior living outside Dallas, Texas, who now works with Free the Pill as a youth advocate, said teens will have sex anyway.

Easier access to contraception and quality education about reproductive health would go farther to protect young people, she said.

“I think they underestimate teens,” Lopez said.

Copyright © 2023, ABC Audio. All rights reserved.

COVID vaccine effectiveness against omicron fell to 20% after six months but protection against severe disease still strong: Study

COVID vaccine effectiveness against omicron fell to 20% after six months but protection against severe disease still strong: Study
COVID vaccine effectiveness against omicron fell to 20% after six months but protection against severe disease still strong: Study
Images By Tang Ming Tung/Getty Images

(NEW YORK) — COVID-19 vaccine effectiveness against omicron infection fell to less than 20% after six months, according to a new analysis published Wednesday.

Researchers from Italy and the United States looked at some of the most common vaccines used around the world, including Pfizer-BioNTech, Moderna, AstraZeneca and Sinovac.

The researchers, however, did not look at the updated bivalent vaccines that target the original strain of the virus as well as BA.4 and BA.5, which are subvariants of omicron.

For the analysis, published in JAMA Network Open, the team examined 40 studies — a combination of articles and reviews published in peer-reviewed journals and preprints.

After receiving a primary series, protection against symptomatic disease decreased from 52.8% at one month after the last dose to 14.3% at six months to 8.9% at nine months.

When it came to vaccine effectiveness against overall infection, protection fell from 44.4% at one month to 20.7% at six months to 13.4% at nine months.

There were some differences in vaccine products from Pfizer and Moderna; they had higher effectiveness than the AstraZeneca and Sinovac vaccines.

Dr. John Brownstein, an epidemiologist and chief innovation officer at Boston Children’s Hospital who was not involved in the study, said the results are not surprising because researchers have known about waning effectiveness for quite some time.

“However this study provides important insights into the specific effectiveness of the original monovalent vaccines against omicron and highlights the importance of the updated bivalent booster in providing additional protection,” said Brownstein, an ABC News contributor.

Studies from the Centers for Disease Control and Protection show that the updated bivalent boosters enhance levels of protection.

One study found the bivalent booster slashed the risk of visiting an emergency department, urgent care facility or hospital due to COVID-19 by at least half for U.S. adults.

Another showed the bivalent booster provided additional protection against symptomatic infection with the two variants of omicron currently circulating, XBB and XBB.1.5, for at least three months in those who received two to four doses of the original vaccine.

“While effectiveness against infection is an important metric, effectiveness against severe disease, hospitalization and death are crucial metrics when evaluating the overall effectiveness of COVID vaccines, as these outcomes have the most significant impact on public health,” Brownstein said.

The analysis also looked at protection when receiving the original booster dose. Levels of protectiveness increased but eventually waned as well.

Against infection, booster effectiveness fell from 55.4% at one month to 28.9% at nine months. Against symptomatic disease, effectiveness declined from 60.4% at one month to 13.3% at nine months.

Brownstein said it’s important to reiterate that vaccination is still very important — to protect both ourselves and those who are at risk of severe disease — and to not interpret the study to mean vaccines aren’t effective.

As of March 19, the latest date for which CDC data is available, COVID-19 cases were 81.11 per 100,000 among unvaccinated people compared to 26.66 per 100,000 for those vaccinated without the updated booster and 25.81 per 100,000 for those vaccinated with the updated booster.

Death rates as of Feb. 26, similarly, had a large gap with 1.07 per 100,000 deaths for those unvaccinated, 0.21 per 100,000 for those vaccinated without the updated booster and 0.19 per 100,000 for those vaccinated with the updated booster.

“The findings from this study shouldn’t detract from the importance of vaccination,” Brownstien said. “While the effectiveness of vaccines against omicron infection may wane over time, vaccines still provide significant protection against severe disease, hospitalization and death.”

He added, “Additionally, booster doses can help maintain protection against the virus especially when they are more closely matched to circulating variants.

ABC News’ Youri Benadjaoud contributed to this report.

Copyright © 2023, ABC Audio. All rights reserved.

Maria Menounos diagnosis puts spotlight on pancreatic cancer

Maria Menounos diagnosis puts spotlight on pancreatic cancer
Maria Menounos diagnosis puts spotlight on pancreatic cancer
Rodin Eckenroth/Getty Images

(NEW YORK) — TV personality Maria Menounos is opening up about a recent health scare, revealing details of a private battle with pancreatic cancer.

Menounos, 44, told People magazine she began experiencing symptoms including “excruciating abdominal pain” late last year.

When the pain continued after test results came back inconclusive, Menounos said she underwent a whole-body MRI that found a mass on her pancreas.

“I’m like ‘How in the freaking world can I have a brain tumor and pancreatic cancer?'” Menounos told People. “All I could think was that I have a baby coming.”

Menounos announced in February that she and her husband Keven Undergaro are expecting their first child via surrogate. Previously, the couple’s decade-long plans to have a child were put on hold in 2017 when Menounos underwent surgery to remove a benign brain tumor.

Menounos said that after doctors found the mass on her pancreas, a biopsy determined it to be a Stage 2 pancreatic neuroendocrine tumor, a type of pancreatic cancer where the tumor forms in the islet cells of the pancreas, according to the National Cancer Institute.

In February, Menounos said she underwent surgery to remove the mass on her pancreas, as well as her spleen, a fibroid and 17 lymph nodes.

“It was super painful,” she said of her recovery from the surgery. “I couldn’t move or lift myself up.”

Because the cancer was caught early, Menounos did not require any chemotherapy and will not need additional treatment, according to People. Her doctor, Dr. Ryan Aronin, and surgeon, Dr. Timothy Donahue, told the outlet Menounos will need annual scans for the next five years.

“I’m so grateful and so lucky,” Menounos said, adding of her daughter, who is due this summer, “God granted me a miracle. I’m going to appreciate having her in my life so much more than I would have before this journey.”

What to know about pancreatic cancer

Pancreatic cancer represents around 3% of new cases of cancer in the United States, but around 8% of cancer deaths, according to the National Cancer Institute.

Most recently, the disease has been in the headlines with the deaths of Alex Trebek, Patrick Swayze and Sex and the City star Willie Garson. All three died of pancreatic cancer.

Pancreatic cancer is a type of cancer that develops from two types of cells in the pancreas, a six-inch-long gland that lays between the stomach and spine, according to the National Cancer Institute.

Pancreatic neuroendocrine tumors, the type of cancer Menounos said she faced, are less common but have a better prognosis. Cancer in the exocrine cells is usually found at a later stage and therefore typically has a worse prognosis, according to the National Cancer Institute.

Overall, the five-year survival rate for pancreatic cancer is just over 12%, according to National Cancer Institute data.

While some pancreatic tumors may not produce any symptoms, others may cause symptoms like diarrhea, pain in the abdomen or back, a lump in the abdomen or yellowing of the skin and eyes, according to the National Cancer Institute.

In many cases, symptoms of pancreatic cancer may not appear until the cancer has spread.

“Part of the reason it tends to be so deadly has to do with anatomy,” ABC News chief medical correspondent Dr. Jennifer Ashton said in 2020, following Trebek’s death due to pancreatic cancer. “If you look at where the pancreas is located, it sits high up in the abdominal cavity. You can’t palpate it or feel it on a physical exam.”

She continued, “By the time it’s producing symptoms, like yellowness of the skin and eyes or weight loss, it’s generally metastasized or spread to an advanced stage.”

Making pancreatic cancer even more difficult to diagnose is that there is no screening test for it, according to Ashton.

Treatment for pancreatic cancer can include everything from surgery to chemotherapy and radiation therapy, as well as new targeted therapies.

Currently, the cause of pancreatic cancer is not known. Risk factors include family history, tobacco use, being overweight, diabetes and more, according to the American Cancer Society.

Copyright © 2023, ABC Audio. All rights reserved.

How to protect kids from the negative impacts of diet culture

How to protect kids from the negative impacts of diet culture
How to protect kids from the negative impacts of diet culture
Virginia Sole-Smith/Instagram

(NEW YORK) — Children are often exposed to diet culture from a young age and its negative impacts can be long-lasting, according to author Virginia Sole-Smith.

Sole-Smith is the author of a new book titled Fat Talk: Parenting in the Age of Diet Culture, which takes a closer look at how kids are exposed to body shaming, diet culture, fatphobia and more.

Young people are listening and the pressure to look a certain way starts early, Sole-Smith told ABC News’ Good Morning America.

“Kids start to learn that fat is the wrong way to have a body between the ages of 3 and 5. This is pressure that starts really early,” Sole-Smith said. “One of the top predictors of future eating disorder risk is kids being shamed for their weight and childhood dieting experiences.”

The pressure continues into adolescence as well. According to data from the National Health and Nutrition Examination Survey from 2013 to 2019, between 2013 and 2016, nearly 37.6% of adolescents aged 16 to 19 reported trying to lose weight within the previous year.

Early exposure to diet culture may be linked to increased social media use. Child psychologist Andrea Vazzana told ABC News in March that she has noticed an increase in younger children with eating disorders, including tweens as young as 9 and 10.

“This may be correlational data, but we’re seeing people joining social media platforms at an earlier age as well,” Vazzana said at the time.

Recovery advocate Sam Dylan Finch told ABC News that although social media can play a positive role in eating disorder recovery, it can also have a negative impact.

“It can be a vehicle for fad diets, health misinformation, harsh criticism, especially for those of us that don’t conform to society’s ideals of beauty and achievement,” Dylan Finch said in March, “and perpetuates standards of perfection that are impossible to achieve.”

Tips to minimize negative diet culture impact

Reclaim the “fat” label

In Fat Talk, Sole-Smith argues that one way parents can fight back against anti-fat bias and diet culture is to reclaim the word “fat.”

“If we can understand fat as just a neutral body descriptor, just like saying tall or short or brown hair, blonde hair … if your child comes to you and they are in a bigger body, and they say, ‘Am I fat?’ you should be honest with them and say, ‘You’re fat.’ And there’s absolutely nothing wrong with that. We love your body just the way it is,” Sole-Smith said.

Define what “fat” means for your family

At the same time, reclaiming the term might not be the right move for every family, according to parenting expert and author Rachel Simmons.

“I think the word ‘fat’ is something everyone needs to make their own choices about,” Simmons said. “I think that the language that we use has to be something that we agree on as a family.”

Change the conversation at home

Another suggestion from Sole-Smith is for parents to shift the conversations with and in front of children at home.

“We can say I’m not going to shame my body in front of my kids and I’m going to celebrate bodies in all shapes and sizes,” the author recommended.

Simmons added separately, “As parents, we need to spend time reminding our children what matters about them on the inside, talk about the strength that your body has no matter what size it is.”

“So if you have a child who is in a bigger body, who’s strong, talk about their strength,” Simmons continued. “Helping our children celebrate how our bodies function, how they allow us to accomplish our goals … these are things we can remind our kids about every single day.”

Oftentimes, diet talk and conversations about size can be unavoidable for children, but Simmons said parents can act as a shield between children and some of the most toxic messages behind diet culture.

As children grow older, Simmons encourages parents to be honest with kids about their own struggles and not pretend they know everything and kids know nothing about diet culture.

If you or someone you know is battling an eating disorder, contact the National Eating Disorders Association (NEDA) at 1-800-931-2237 or NationalEatingDisorders.org.

Copyright © 2023, ABC Audio. All rights reserved.

1st RSV vaccine for older adults in US cleared by FDA in historic approval

1st RSV vaccine for older adults in US cleared by FDA in historic approval
1st RSV vaccine for older adults in US cleared by FDA in historic approval
Xinhua via Getty Images

(WASHINGTON) — The U.S. Food and Drug Administration on Wednesday approved the first RSV vaccine in the U.S.

Scientists have been trying to develop an RSV vaccine for decades after previous high-profile attempts failed.

The vaccine, made by the pharmaceutical company GSK, is for older adults. Pfizer and Moderna are also developing similar RSV vaccines.

The Centers for Disease Control and Prevention still needs to weigh in with specific recommendations, which is expected in June. GSK anticipates it will have enough vaccine to meet demand in time for the fall and winter respiratory illness season.

GSK said it has “millions of doses ready to be shipped.”

Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in a statement: “Older adults, in particular those with underlying health conditions, such as heart or lung disease or weakened immune systems, are at high risk for severe disease caused by RSV. Today’s approval of the first RSV vaccine is an important public health achievement to prevent a disease which can be life-threatening and reflects the FDA’s continued commitment to facilitating the development of safe and effective vaccines for use in the United States.”

RSV is a viral infection that leads to mild illness for most people; however, it can be dangerous for older adults and some young children. RSV is a common cause of lower respiratory tract disease (LRTD), which affects the lungs and can cause life-threatening pneumonia and bronchiolitis, according to the FDA.

Each year between 60,000 and 120,000 older adults are hospitalized due to RSV.

RSV circulation is seasonal, typically starting in the fall and peaking in the winter. Pharmaceutical companies are also working on RSV vaccines that are targeted at young children.

Copyright © 2023, ABC Audio. All rights reserved.

Fentanyl overdose deaths surged 279% since 2016 while heroin deaths fell: CDC

Fentanyl overdose deaths surged 279% since 2016 while heroin deaths fell: CDC
Fentanyl overdose deaths surged 279% since 2016 while heroin deaths fell: CDC
Tetra Images/Getty Images

(NEW YORK) — The rate of drug overdose deaths linked to fentanyl in the United States has skyrocketed over the last five years, new federal data showed.

The rate of overdose deaths involving fentanyl spiked by 279% between 2016 and 2021 from 5.7 per 100,000 to 21.6 per 100,000, according to a report published early Wednesday by the National Center for Health Statistics’ National Vital Statistics System — which looked at death certificate records.

“We are always hoping we won’t see a rise in fentanyl deaths, but this really highlights that this is continuing to be the public health problem,” Merianne Spencer, a co-author of the report and a researcher at the Centers for Disease Control and Prevention, told ABC News.

Although the rate of overdose deaths linked to other drugs also saw increases, they were more modest rises and did not reach the levels of fentanyl.

Deaths linked to methamphetamine quadrupled from 2.1 per 100,000 in 2016 to 9.6 per 100,000 in 2021 and deaths due to cocaine more than doubled from 3.5 per 100,000 to 7.9 per 100,000 over the same period.

“When it comes to overdose, really the biggest driver is folks who are really struggling with addiction primarily on street drugs, which fentanyl is primarily found in terms of the street drug supply rather than a prescription medication,” Dr. Allison Lin, an addiction psychiatrist at University of Michigan Medical School, who was not involved in the report, told ABC News.

“And it’s primarily folks who are struggling with addiction to multiple substances, so oftentimes, folks who are using not only fentanyl, but fentanyl plus cocaine or fentanyl plus methamphetamine,” she said.

Meanwhile, drugs that used to make up the majority of overdose deaths — heroin and oxycodone — saw declines in their rates of death.

Rates of heroin overdose fatalities fell from 4.9 per 100,000 to 2.9 per 100,000 while oxycodone overdose death rates fell slightly from 1.9 per 100,000 to 1.5 per 100,000.

Researchers have noted there has been a marked increase in fentanyl use, and subsequently fentanyl overdoses, as heroin overdoses have fallen.

From 2019 to 2020 alone, the rate of fentanyl deaths linked to fentanyl rose by 55% and by 24.1% from 2020 to 2021, according to the report. The Department of Justice and the FBI announced on Tuesday that 300 people were arrested after a year-long operation tracking the trafficking of fentanyl and opioids on the dark web.

There has been a shift from a heroin-based market to a fentanyl-based market, according to the DOJ’s Drug Enforcement Administration.

“The vast majority of our folks or patients with substance use disorders, even if they don’t know it, they’re primarily using the drug supply that’s primarily fentanyl,” Lin said. “So, the folks who were using heroin previously are the folks who are also using fentanyl now. It’s just that the supply of opioids and other drugs in our communities are primarily supplies that are predominantly fentanyl because of all the characteristics of it, how inexpensive it is, how easy it is to cut with other substances, other factors.”

However, the CDC said the decrease in heroin-related deaths is also linked to increased treatments for people who use heroin, as well as increased access to naloxone, which reverses opioid overdoses.

Data showed that, for all five drugs analyzed in 2021, men had higher rates of death than women. The widest gap was when it came to rates of death due to heroin with men having a rate nearly three times higher at 4.2 per 100,000 compared to 1.5 per 100,000 for women.

In 2021, among all age groups, fentanyl was the drug with the highest overdose death rates. However, rates were highest among those aged 35 to 44 at 43.5 per 100,000 and those aged 25 to 34 at 40.8 per 100,000.

For Americans between ages 45 and 64, while the rates were highest for fentanyl, the rates were similar to deaths involving cocaine and methamphetamine.

Meanwhile, for those aged 24 younger and those aged 65 and older, death rates were highest for fentanyl but not significantly different from deaths due to methamphetamine, cocaine, heroin and oxycodone.

Similarly, while fentanyl has the highest death rate across every racial/ethnic group, some groups have been affected by different drugs.

American Indians/Alaska Natives saw a fentanyl overdose death rate of 33.1 per 100,000 in 2021, but it was closely followed by methamphetamine at 27.4 per 100,000. Black Americans had a fentanyl death rate of 31.3 per 100,000 closely followed by a cocaine rate of 20.6 per 100,000.

Drug cartels have specifically targeted Native American reservations, leading to higher use of methamphetamine among this population than any other group, according to the Department of Justice. Additionally, Black Americans and African Americans have been disproportionately affected by use of crack cocaine.

“The fact that for American Indians/Alaskan Natives, it was fentanyl followed by meth and for non-Hispanic Black Americans and African Americans it was fentanyl followed by cocaine, that’s an important highlight,” Spencer said. “Within each group, the drug ranking varies slightly.”

Lin said this is evidence that even if fentanyl is now the primary drug of focus, the epidemic related to cocaine and meth has not disappeared.

“There are going to be different substances, different factors that affect different groups,” she said. “Unfortunately, we see death rates and overdose rates rise across all of these groups, because of the factor of fentanyl.”

Lin added, “It doesn’t mean that we’ve ever addressed the crack epidemic, I would say, and we also have a rising meth epidemic in the country as well and everything is just made worse [because] these are not just single substance that people are using anymore. They’re really oftentimes combined with fentanyl.”

Copyright © 2023, ABC Audio. All rights reserved.

US Surgeon General calls for action regarding the ongoing ‘epidemic of loneliness and isolation’

US Surgeon General calls for action regarding the ongoing ‘epidemic of loneliness and isolation’
US Surgeon General calls for action regarding the ongoing ‘epidemic of loneliness and isolation’
xijian/Getty Images

(NEW YORK) — The U.S. Surgeon General released an advisory on Tuesday calling attention to the public health crisis of loneliness, isolation and lack of connection in the United States.

“Lacking connection increases the risk for premature death to more than 60%. Put simply, this social disconnection increases the risk for premature death to the same levels as smoking up to 15 cigarettes a day,” U.S. Surgeon General Dr. Vivek Murthy said in a statement.

The report cites recent research showing that approximately half of U.S. adults experienced loneliness daily, even before the onset of the COVID-19 pandemic.

It highlights that a lack of social connection can present significant health risks, as loneliness can increase risk of premature death by 26% and social isolation by 29%, according to a meta-analysis cited in the advisory.

According to the report, insufficient social connection has also been linked to an increased risk of heart disease, stroke, anxiety, depression and dementia.

Additionally, loneliness was reported among the primary motivations for self-harm, according to a systematic review cited in the advisory.

“Given the profound consequences of loneliness and isolation, we have an opportunity, an obligation, to make the same investments in addressing social connection that we have made in addressing tobacco use, obesity and the addiction crisis,” Murthy said.

Social connection can reduce the health risks associated with isolation and loneliness. One study found that frequently confiding in others is associated with up to 15% reduced odds of developing depression among people who are at higher risk due to a history of traumatic or adverse life experiences.

The advisory lays out a framework for a National Strategy to Advance Social Connection, which provides recommendations for individuals, governments, workplaces, health systems and community organizations that aim to increase social connection and improve overall health. This type of strategy has never been implemented before in the United States.

These recommendations include infrastructure changes, such as developing parks and libraries that enhance social connection, policy changes allowing for paid family leave and accessible public transportation, and more research to efficiently address social isolation.

The framework also includes training for healthcare providers to allow for intervention if a patient is at risk for loneliness and its significant health consequences. It also notes that digital environments should be further evaluated, particularly how online interactions can potentially hinder meaningful connections.

Lastly, the recommendations call for the cultivation of a culture of connection, stating that the informal interactions of everyday life can significantly influence social connection.

“By taking small steps every day to strengthen our relationships, we can rise to meet this moment together… And we can ensure our country and the world are better posed than ever to take on the challenges that lay ahead,” Murthy said.

There are some immediate steps you can take to reduce loneliness and increase social connection, such as reaching out to a friend or family member.

“People often incorrectly assume that disclosing painful truths or emotions with a trusted other will be a turn off or perceived as a burden. Quite the opposite typically occurs,” Justin Baker, the clinical director of the Suicide and Trauma Reduction Initiative (STRIVE), told ABC News.

“Instead of feeling like a burden, sharing a common struggle typically brings people together and strengthens the existing relationship,” Baker said.

If you are experiencing suicidal thoughts, substance use or other mental health crises please call or text 988. Trained crisis counselors are available for free, 24 hours a day, seven days a week.

Copyright © 2023, ABC Audio. All rights reserved.

Nevada reports cluster of rare brain infection in children in 2022

Nevada reports cluster of rare brain infection in children in 2022
Nevada reports cluster of rare brain infection in children in 2022
Camelia Ciocirlan / 500px / Getty Images

(CLARK COUNTY, Nev.) — Health officials are investigating an increase of a rare brain infection occurring in kids in Nevada, according to the U.S. Centers for Disease Control and Prevention.

The Southern Nevada Health District (SNHD) reported in October a “higher than expected” number of pediatric patients in Clark County who have intracranial abscesses.

There were 18 cases of intracranial abscesses found in children in 2022, up from about four cases per year between 2015 and 2021, which is more than triple the amount, according to SNHD.

According to the report, there were an average of seven cases during 2020 and 2021, at the height of the COVID-19 pandemic.

A cerebral abscess is a pus-filled pocket of an infection in your brain, according to Johns Hopkins Medicine.

The abscess can cause swelling in the brain, which places harmful pressure on brain tissue and can prevent blood from flowing to parts of the brain, according to Johns Hopkins.

“A cerebral abscess usually occurs when bacteria or fungi make their way into your brain, either through your bloodstream or from an infected area in your head, such as your ears or sinuses,” John Hopkins Medicine said on its site. “An injury to your head or head surgery can also let in germs that can cause an abscess.”

Headaches, fevers, chills, nausea, vomiting and seizures are some symptoms caused by the brain abscess, according to Johns Hopkins Medicine.

According to the Southern Nevada Health District’s findings, most of the cases occurred in males with a median age of 12 years old. The most common bacterial pathogen was Streptococcus intermedius, found in 33% of patients. Fifteen out of the 18 patients required craniotomies, according to the report.

No deaths were reported, according to SNHD. However, death is possible if left untreated, according to Johns Hopkins.

Medical professionals can treat cerebral abscesses with strong antibiotics and other medications, such as steroids and drugs to prevent seizures, according to John Hopkins Medicine.

Copyright © 2023, ABC Audio. All rights reserved.

New book busts myths, answers common questions about menopause

New book busts myths, answers common questions about menopause
New book busts myths, answers common questions about menopause
Author Jancee Dunn talks about her new book, “Hot and Bothered: What no one tells you about menopause,” on ABC’s “Good Morning America,” May 1, 2023. — ABC News

(NEW YORK) — As more women pull back the curtain on their journeys with menopause — a topic that previously felt taboo to discuss openly — Jancee Dunn dives into the subject in her new book, Hot and Bothered: What No One Tells You About Menopause.

For Dunn, the first signs of menopause started when she turned 45.

“I had no idea what it was. I wasn’t in that space at all,” she told Good Morning America.

While there were plenty of pregnancy books on the shelves, Dunn said she found just one outdated book on menopause from the ’90s. So she set out to change that, spoke with experts in the field and wrote the book she wished she’d had.

“I really wanted to write a book where there was humor in it and not make it so dire,” she said.

Her book instead offers simple advice on how she handled some of the common symptoms, like hot flashes. “I breathe in, count of five, hold it for eight count, then breathe out. There’s something about giving yourself control,” she said.

Other symptoms she outlined include brain fog, mood change, irregular periods, thinning hair and dry skin.

“[Skin is] probably going to get dryer and more sensitive and your go-to products might not work any more,” Dunn explained from her personal experience. “You want something that gets rid of that dry outer layer. Gentle retinol products can help.”

Dunn also shared her message to women struggling with menopause: “Normalize this transition by talking as much as possible to everyone you know about it. The more we talk about it, the more normal it is. Less scary it is.”

ABC News Chief Medical Correspondent and OB-GYN Dr. Jennifer Ashton shared her expertise to further shed light on the topic and help women better understand the phase of time and transition.

When does menopause begin?

“The average age of menopause in this country is 51. It can start as early as 45 or even earlier,” Ashton said. “Perimenopause can start 10 years before menopause actually begins.”

What is perimenopause?

“Our definition is one year without a menstrual period,” Ashton said.

What are the perimenopause symptoms?

The head-to-toe symptoms, as Ashton called it, include “bleeding patterns can change, mood swings, skin changes, hair change [and] weight changes.”

“It is so pervasive and so distinctive woman to woman that we tend to say to a woman 40 and up, ‘If you are experiencing something new, something different, think hormonal, think perimenopause or menopause first.’ That’s how diverse and broad the signs and symptoms are,” Ashton said.

Recommendations for menopause symptoms

“The first thing we have to remember is that hormone replacement therapy is and should be an option on the table for the vast majority of women,” Ashton said, adding that “women should talk to their gynecologist about that.”

When it comes to hot flashes specifically, Ashton said, “There are numerous non-hormonal prescription medications that work very effectively.”

Additionally, she said wellness behaviors can help, such as getting exercise and avoiding alcohol, caffeine and spicy foods, which, she says, can trigger the onset of a hot flash.

What to know about hormone replacement therapy

“Women have to discuss this with their gynecologist,” she encouraged.

While some are weary of the treatment, Ashton pointed to the 2002 Women’s Health Initiative trial, in which “data was boiled down to a misleading headline: ‘Hormones bad, hormones dangerous.’ Now, there are oncologists who actually, in evaluating the data both past and present, really find that most data suggests and shows conclusively that estrogen does not increase the risk of breast cancer.”

When it comes to other conditions that affect women, Ashton said, “Heart disease, osteoporosis and dementia cause more deaths than breast cancer and there are some real benefits to hormones.”

Copyright © 2023, ABC Audio. All rights reserved.